Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelius Engelmann

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Journal of Hepatology|July 17, 2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFCornelius Engelmann, Abeba Habtesion, Mohsin Hassan, et al.
Purinergic Signalling|September 24, 2018
Mononuclear-cell-derived microparticles attenuate endothelial inflammation by transfer of miR-142-3p in a CD39 dependent mannerStephanie Kuhn, Katrin Splith, Cindy Ballschuh, et al.
JHEP Reports : Innovation in Hepatology|January 19, 2026
Effects of hypothermic oxygenated machine perfusion on bile composition after liver transplantation - Findings from a randomized controlled trialFrederik Schliephake, Isabella Lurje, Deniz Uluk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pumpGuido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2018
Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and deathCornelius Engelmann, Stefan Schob, Ines Nonnenmacher, et al.
Journal of Hepatology|August 14, 2025
Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosisNipun Verma, Pratibha Garg, Parminder Kaur, et al.
Cancers|February 25, 2022
Prognostic and Predictive Molecular Markers in CholangiocarcinomaSandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Hepatology Communications|April 1, 2026
Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitisAlena Laschtowitz, Clara Vom Endt, Martin Kluge, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term Outcomes After Curative-Intent Surgery for Hepatocellular CarcinomaDeniz Uluk, Justus Pein, Sophia Herda, et al.
Journal of Hepatology|January 29, 2020
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failureCornelius Engelmann, Mohammed Sheikh, Shreya Sharma, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Journal of Hepatology|July 17, 2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFCornelius Engelmann, Abeba Habtesion, Mohsin Hassan, et al.
Purinergic Signalling|September 24, 2018
Mononuclear-cell-derived microparticles attenuate endothelial inflammation by transfer of miR-142-3p in a CD39 dependent mannerStephanie Kuhn, Katrin Splith, Cindy Ballschuh, et al.
JHEP Reports : Innovation in Hepatology|January 19, 2026
Effects of hypothermic oxygenated machine perfusion on bile composition after liver transplantation - Findings from a randomized controlled trialFrederik Schliephake, Isabella Lurje, Deniz Uluk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 10, 2022
Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pumpGuido Stirnimann, Thomas Berg, Laurent Spahr, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2018
Loss of paraspinal muscle mass is a gender-specific consequence of cirrhosis that predicts complications and deathCornelius Engelmann, Stefan Schob, Ines Nonnenmacher, et al.
Journal of Hepatology|August 14, 2025
Identification and validation of RIPK3 as a novel biomarker to predict outcomes in patients with acutely decompensated cirrhosisNipun Verma, Pratibha Garg, Parminder Kaur, et al.
Cancers|February 25, 2022
Prognostic and Predictive Molecular Markers in CholangiocarcinomaSandra Pavicevic, Sophie Reichelt, Deniz Uluk, et al.
Hepatology Communications|April 1, 2026
Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitisAlena Laschtowitz, Clara Vom Endt, Martin Kluge, et al.
Alimentary Pharmacology & Therapeutics|February 18, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Impacts Long-Term Outcomes After Curative-Intent Surgery for Hepatocellular CarcinomaDeniz Uluk, Justus Pein, Sophia Herda, et al.
Journal of Hepatology|January 29, 2020
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failureCornelius Engelmann, Mohammed Sheikh, Shreya Sharma, et al.
Pageof 11